TN2009000529A1 - Methods and compositions for treating allergic diseases - Google Patents
Methods and compositions for treating allergic diseasesInfo
- Publication number
- TN2009000529A1 TN2009000529A1 TNP2009000529A TN2009000529A TN2009000529A1 TN 2009000529 A1 TN2009000529 A1 TN 2009000529A1 TN P2009000529 A TNP2009000529 A TN P2009000529A TN 2009000529 A TN2009000529 A TN 2009000529A TN 2009000529 A1 TN2009000529 A1 TN 2009000529A1
- Authority
- TN
- Tunisia
- Prior art keywords
- methods
- compositions
- allergic diseases
- treating allergic
- antibodies
- Prior art date
Links
- 208000026935 allergic disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 101000956427 Homo sapiens Cytokine receptor-like factor 2 Proteins 0.000 abstract 1
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 abstract 1
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94520507P | 2007-06-20 | 2007-06-20 | |
| PCT/EP2008/057731 WO2008155365A1 (fr) | 2007-06-20 | 2008-06-18 | Procédés et compositions pour traiter des maladies allergiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2009000529A1 true TN2009000529A1 (en) | 2011-03-31 |
Family
ID=39846944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2009000529A TN2009000529A1 (en) | 2007-06-20 | 2009-12-17 | Methods and compositions for treating allergic diseases |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8101182B2 (fr) |
| EP (1) | EP2170957A1 (fr) |
| JP (1) | JP2010530233A (fr) |
| KR (1) | KR20100034015A (fr) |
| CN (1) | CN102027012A (fr) |
| AR (1) | AR067045A1 (fr) |
| AU (1) | AU2008265128A1 (fr) |
| BR (1) | BRPI0813725A2 (fr) |
| CA (1) | CA2691157A1 (fr) |
| CL (1) | CL2008001826A1 (fr) |
| CO (1) | CO6251325A2 (fr) |
| CR (1) | CR11152A (fr) |
| EA (1) | EA201000006A1 (fr) |
| EC (1) | ECSP099812A (fr) |
| IL (1) | IL202573A0 (fr) |
| PE (1) | PE20090768A1 (fr) |
| TN (1) | TN2009000529A1 (fr) |
| TW (1) | TW200918557A (fr) |
| WO (1) | WO2008155365A1 (fr) |
| ZA (1) | ZA200908711B (fr) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2349762C (fr) | 1998-11-13 | 2013-12-24 | Immunex Corporation | Polypeptides de lymphopoietine de stroma thymique humain (tslp), adn et polypeptides associes |
| ES2422879T3 (es) | 2001-07-23 | 2013-09-16 | Immunex Corporation | Linfopoyetina estromal tímica humana modificada |
| US20090176654A1 (en) * | 2007-08-10 | 2009-07-09 | Protelix, Inc. | Universal fibronectin type III binding-domain libraries |
| US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
| US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| AR070346A1 (es) * | 2008-02-07 | 2010-03-31 | Schering Corp | Anticuerpo especifico del receptor de linfopoyetina estromal timica (tslpr) y usos en trastornos inflamatorios e inflamatorios alergicos |
| TW201201840A (en) * | 2010-07-15 | 2012-01-16 | Hoffmann La Roche | Antibodies specifically binding to human TSLPR and methods of use |
| KR101221649B1 (ko) * | 2010-11-01 | 2013-01-14 | 광주과학기술원 | 알러지 질환의 예방 또는 치료용 약제학적 조성물, 그의 스크리닝 방법 |
| RS58696B1 (sr) | 2013-08-09 | 2019-06-28 | Astellas Pharma Inc | Novo antitelo protiv humanog tslp receptora |
| MX388536B (es) | 2014-05-07 | 2025-03-20 | Amgen Inc | Autoinyector con elementos reductores del shock. |
| JP6671298B2 (ja) | 2014-05-16 | 2020-03-25 | アムジェン インコーポレイテッド | Ｔｈ１及びｔｈ２細胞集団を検出するためのアッセイ |
| JP6822843B2 (ja) | 2014-06-03 | 2021-01-27 | アムジエン・インコーポレーテツド | 薬物送達装置によって収集されたデータを遠隔で処理するためのシステム及び方法 |
| AU2015332557B2 (en) | 2014-10-14 | 2020-05-14 | Amgen Inc. | Drug injection device with visual and audio indicators |
| BR112017008125B1 (pt) | 2014-10-23 | 2023-11-21 | Amgen Inc. | Método para a redução da viscosidade de formulações farmacêuticas, formulações farmacêuticas, método de preparação de um pó liofilizado, pó liofilizado e método para reconstituição de um pó liofilizado |
| WO2016100055A1 (fr) | 2014-12-19 | 2016-06-23 | Amgen Inc. | Dispositif d'administration de médicament ayant un bouton direct ou un champ d'interface utilisateur |
| EP3258988B1 (fr) | 2015-02-17 | 2019-08-28 | Amgen Inc. | Dispositif d'administration de médicament à sécurisation assistée par dépression et/ou retour d'informations |
| JP2018512184A (ja) | 2015-02-27 | 2018-05-17 | アムジエン・インコーポレーテツド | 針ガードの移動に対する抵抗力の閾値が調整可能な針ガード機構を備えた薬物送達装置 |
| WO2017039786A1 (fr) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Adaptateur d'ensemble de seringue pour une seringue |
| AU2016320748B2 (en) | 2015-09-09 | 2019-05-02 | Novartis Ag | Thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of using the antibodies |
| LT3347377T (lt) | 2015-09-09 | 2021-05-25 | Novartis Ag | Užkrūčio liaukos stromos limfopoetiną (tslp) rišantys antikūnai ir antikūnų panaudojimo būdai |
| US11351308B2 (en) | 2015-12-09 | 2022-06-07 | Amgen Inc. | Auto-injector with signaling cap |
| WO2017104778A1 (fr) | 2015-12-18 | 2017-06-22 | アステラス製薬株式会社 | Composition pharmaceutique contenant un anticorps anti-récepteur de la tslp humaine |
| US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
| EP3721922B1 (fr) | 2016-03-15 | 2022-05-04 | Amgen Inc. | Réduction de la probabilité de rupture de verre dans des dispositifs d'administration de médicament |
| US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
| WO2017192287A1 (fr) | 2016-05-02 | 2017-11-09 | Amgen Inc. | Adaptateur de seringue et guide pour remplir un injecteur sur le corps |
| ES2959783T3 (es) | 2016-05-13 | 2024-02-28 | Amgen Inc | Conjunto de cubierta protectora de vial |
| WO2017200989A1 (fr) | 2016-05-16 | 2017-11-23 | Amgen Inc. | Chiffrement de données dans des dispositifs médicaux à capacité de calcul limitée |
| EP3465124A1 (fr) | 2016-06-03 | 2019-04-10 | Amgen Inc. | Appareils et procédés d'essai au choc destinés aux dispositifs d'administration de médicaments |
| US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
| WO2018034784A1 (fr) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Dispositif d'administration de médicament avec détection de positionnement. |
| US20200261643A1 (en) | 2016-10-25 | 2020-08-20 | Amgen Inc. | On-body injector |
| AU2018210301A1 (en) | 2017-01-17 | 2019-08-01 | Amgen Inc. | Injection devices and related methods of use and assembly |
| EP3582825A1 (fr) | 2017-02-17 | 2019-12-25 | Amgen Inc. | Dispositif d'administration de médicament à trajet d'écoulement de fluide stérile et procédé d'assemblage associé |
| AU2018221351B2 (en) | 2017-02-17 | 2023-02-23 | Amgen Inc. | Insertion mechanism for drug delivery device |
| JP7377596B2 (ja) | 2017-02-22 | 2023-11-10 | アムジエン・インコーポレーテツド | 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法 |
| JP2020508803A (ja) | 2017-03-06 | 2020-03-26 | アムジエン・インコーポレーテツド | 作動防止特徴部を備える薬物送達デバイス |
| KR102627069B1 (ko) | 2017-03-07 | 2024-01-18 | 암겐 인코포레이티드 | 과압에 의한 바늘 삽입 |
| CA3052310A1 (fr) | 2017-03-09 | 2018-09-13 | Amgen Inc. | Mecanisme d'insertion pour dispositif d'administration de medicament |
| BR112019020053B1 (pt) | 2017-03-28 | 2023-10-10 | Amgen Inc | Máquina para acoplar uma haste de êmbolo a um conjunto de seringa e método de utilização da referida máquina |
| EP3615069B1 (fr) | 2017-04-28 | 2025-05-28 | Amgen Inc. | Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques |
| AU2018282077B2 (en) | 2017-06-08 | 2023-11-23 | Amgen Inc. | Torque driven drug delivery device |
| US11590294B2 (en) | 2017-06-08 | 2023-02-28 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
| MX2019015472A (es) | 2017-06-22 | 2020-02-19 | Amgen Inc | Reduccion del impacto/choque de la activacion del mecanismo. |
| EP3641861A1 (fr) | 2017-06-23 | 2020-04-29 | Amgen Inc. | Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur |
| EP3651832B1 (fr) | 2017-07-14 | 2023-12-13 | Amgen Inc. | Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion |
| EP4292576A3 (fr) | 2017-07-21 | 2024-01-17 | Amgen Inc. | Élément d'étanchéité perméable aux gaz pour récipient de médicament et procédés d'assemblage |
| MA49677A (fr) | 2017-07-25 | 2021-04-21 | Amgen Inc | Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé |
| US11484648B2 (en) | 2017-07-25 | 2022-11-01 | Amgen Inc. | Drug delivery device with container access system and related method of assembly |
| EA202090380A1 (ru) | 2017-08-01 | 2020-05-21 | Эмджен Инк. | Системы и способы для выполнения анализа гликанов в образце в режиме реального времени |
| ES2978396T3 (es) | 2017-08-01 | 2024-09-11 | Amgen Inc | Sistemas y métodos para la preparación en tiempo real de una muestra de polipéptidos para el análisis por espectrometría de masas |
| US12318593B2 (en) | 2017-08-09 | 2025-06-03 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
| EP3668567A1 (fr) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Injecteur sur-corps avec patch adhésif stérile |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| ES2939292T3 (es) | 2017-10-04 | 2023-04-20 | Amgen Inc | Adaptador de flujo para dispositivo de administración de fármacos |
| MA50614A (fr) | 2017-10-06 | 2020-08-12 | Amgen Inc | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé |
| EP3694578B1 (fr) | 2017-10-09 | 2025-09-24 | Amgen Inc. | Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé |
| WO2019090079A1 (fr) | 2017-11-03 | 2019-05-09 | Amgen Inc. | Système et approches pour stériliser un dispositif d'administration de médicament |
| ES2994389T3 (en) | 2017-11-06 | 2025-01-23 | Amgen Inc | Drug delivery device with placement and flow sensing |
| MA50569A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Ensembles de remplissage-finition et procédés associés |
| SG11202002966QA (en) | 2017-11-10 | 2020-05-28 | Amgen Inc | Plungers for drug delivery devices |
| WO2019099324A1 (fr) | 2017-11-16 | 2019-05-23 | Amgen Inc. | Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament |
| JP7657052B2 (ja) | 2018-03-13 | 2025-04-04 | アムジエン・インコーポレーテツド | 質量分光測定分析のためのトリプシン耐性ポリペプチドを調製するための方法 |
| JP7411560B2 (ja) | 2018-03-13 | 2024-01-11 | アムジエン・インコーポレーテツド | 質量分光測定法による分析のためのポリペプチドの連続消化 |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| KR102682705B1 (ko) * | 2018-07-04 | 2024-07-05 | 고려대학교 세종산학협력단 | 옥사졸로퀴놀리논 유도체를 유효성분으로 포함하는 우울증 및 스트레스 관련 질환의 예방 또는 치료용 약학 조성물 |
| MX2021000748A (es) | 2018-07-24 | 2021-03-26 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
| CN112351804A (zh) | 2018-07-24 | 2021-02-09 | 安进公司 | 用于施用药物的输送装置 |
| WO2020023336A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs hybrides d'administration de médicament dotés d'une partie de préhension |
| US12303677B2 (en) | 2018-07-24 | 2025-05-20 | Amgen Inc. | Hybrid drug delivery devices with optional grip portion and related method of preparation |
| MA53320A (fr) | 2018-07-31 | 2021-11-03 | Amgen Inc | Ensemble de trajet de fluide pour dispositif d'administration de médicament |
| WO2020068623A1 (fr) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Systèmes et procédés de dosage interventionnel |
| EP3856283A1 (fr) | 2018-09-28 | 2021-08-04 | Amgen Inc. | Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament |
| US12156991B2 (en) | 2018-10-02 | 2024-12-03 | Amgen Inc. | Injection systems for drug delivery with internal force transmission |
| US12151089B2 (en) | 2018-10-05 | 2024-11-26 | Amgen Inc. | Drug delivery device having dose indicator |
| IL281894B2 (en) | 2018-10-15 | 2024-12-01 | Amgen Inc | Drug delivery device having damping mechanism |
| MA53913A (fr) | 2018-10-15 | 2022-01-19 | Amgen Inc | Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| MA54057A (fr) | 2018-11-01 | 2022-02-09 | Amgen Inc | Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament |
| ES3010833T3 (en) | 2018-11-01 | 2025-04-04 | Amgen Inc | Drug delivery devices with partial drug delivery member retraction |
| US12000775B2 (en) | 2018-12-14 | 2024-06-04 | Amgen Inc. | System suitability method for use with protein concentration determination by slope |
| WO2020168156A1 (fr) | 2019-02-14 | 2020-08-20 | Amgen Inc. | Systèmes et procédés de préparation d'un échantillon et de réalisation d'un dosage en temps réel de l'échantillon |
| JP7530376B2 (ja) | 2019-02-20 | 2024-08-07 | アムジエン・インコーポレーテツド | タンパク質の安定性を決定する方法 |
| JP7570341B2 (ja) | 2019-03-04 | 2024-10-21 | アムジエン・インコーポレーテツド | 高分子量種のインビボでの可逆性 |
| WO2020198538A1 (fr) | 2019-03-27 | 2020-10-01 | Amgen Inc. | Méthodes de cartographie de protéines thérapeutiques par l'intermédiaire d'une technique de résonance magnétique nucléaire bidimensionnelle (2d) à une abondance naturelle pour produits biopharmaceutiques formulés |
| MX2021012557A (es) | 2019-04-24 | 2021-11-12 | Amgen Inc | Conjuntos y metodos de verificacion de esterilizacion de jeringuillas. |
| US12404323B2 (en) | 2019-06-04 | 2025-09-02 | Jiangsu Hengrui Medicine Co., Ltd | Antibody capable of binding to thymic stromal lymphopoietin and use thereof |
| EP4517327A3 (fr) | 2019-06-05 | 2025-05-07 | Amgen Inc. | Procédés d'identification d'attributs de protéines thérapeutiques |
| CA3148261A1 (fr) | 2019-08-23 | 2021-03-04 | Amgen Inc. | Dispositif d'administration de medicament dote de composants configurables de mise en prise de protection d'aiguille et methodes associees |
| HRP20250300T1 (hr) | 2019-10-28 | 2025-04-25 | Medimmune Limited | Suhe praškaste formulacije protutijela koja se vežu na timusni stromalni limfopoetin (tslp) i postupci za njihovu uporabu |
| CN111171150B (zh) * | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
| AU2021343495A1 (en) | 2020-09-18 | 2023-04-27 | Amgen Inc. | Methods of processing a sample for peptide mapping analysis |
| AU2021376246A1 (en) | 2020-11-05 | 2023-06-08 | Amgen Inc. | Materials and methods for protein processing |
| US20240208680A1 (en) | 2021-05-21 | 2024-06-27 | Amgen Inc. | Method of optimizing a filling recipe for a drug container |
| TW202325853A (zh) | 2021-11-09 | 2023-07-01 | 美商安進公司 | 治療性蛋白之生產 |
| WO2024102675A1 (fr) | 2022-11-07 | 2024-05-16 | Upstream Bio, Inc. | Compositions pharmaceutiques comprenant des anticorps anti-récepteur de la tslp humaine et procédés d'utilisation de celles-ci |
| WO2024259275A1 (fr) | 2023-06-14 | 2024-12-19 | Bristol-Myers Squibb Company | Quantification en temps quasi réel d'acide sialique de glycoprotéines |
| WO2025101602A1 (fr) | 2023-11-07 | 2025-05-15 | Amgen Inc. | Procédés d'analyse de la teneur en acides aminés d'une protéine thérapeutique |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1982990A1 (fr) | 1998-03-19 | 2008-10-22 | Human Genome Sciences, Inc. | Récepteur de cytokine et chaîne de gamma commune similaire |
| WO2002000723A2 (fr) | 2000-06-28 | 2002-01-03 | Whitehead Institute For Biomedical Research | Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci |
| US7964713B2 (en) | 2000-06-28 | 2011-06-21 | Amgen Inc. | Nucleic acid molecules encoding thymic stromal lympopoietin receptor proteins and a process for producing the encoded polypeptides thereof |
| US6890734B2 (en) | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
| EP2311869B2 (fr) * | 2002-02-01 | 2020-06-17 | Merck Sharp & Dohme Corp. | Utilisations d'une cytokine mammifère et réactifs associés |
| EP1651247B1 (fr) * | 2003-07-18 | 2008-09-10 | Schering Corporation | Traitement et diagnostic de neoplasmes au moyen de la lymphopoietine stromale thymique |
| US20050249712A1 (en) | 2004-03-23 | 2005-11-10 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for use of TSLP and agonists and antagonists thereof |
| EP1793856A2 (fr) * | 2004-08-20 | 2007-06-13 | Amgen Inc. | Procedes et compositions pour le traitement d'inflammation allergique |
| US20060171943A1 (en) | 2005-02-01 | 2006-08-03 | Amgen Inc. | Compositions and methods of treating fibrotic disorders |
| KR101383472B1 (ko) * | 2006-01-13 | 2014-04-08 | 아이알엠 엘엘씨 | 알레르기 질병 치료를 위한 흉선 간질 림포포이에틴수용체에 대한 항체 |
| AR070346A1 (es) | 2008-02-07 | 2010-03-31 | Schering Corp | Anticuerpo especifico del receptor de linfopoyetina estromal timica (tslpr) y usos en trastornos inflamatorios e inflamatorios alergicos |
-
2008
- 2008-06-18 AR ARP080102594A patent/AR067045A1/es not_active Application Discontinuation
- 2008-06-18 CN CN2008801025460A patent/CN102027012A/zh active Pending
- 2008-06-18 JP JP2010512681A patent/JP2010530233A/ja active Pending
- 2008-06-18 CA CA2691157A patent/CA2691157A1/fr not_active Abandoned
- 2008-06-18 WO PCT/EP2008/057731 patent/WO2008155365A1/fr active Application Filing
- 2008-06-18 AU AU2008265128A patent/AU2008265128A1/en not_active Abandoned
- 2008-06-18 PE PE2008001045A patent/PE20090768A1/es not_active Application Discontinuation
- 2008-06-18 US US12/141,516 patent/US8101182B2/en not_active Expired - Fee Related
- 2008-06-18 EA EA201000006A patent/EA201000006A1/ru unknown
- 2008-06-18 BR BRPI0813725-0A2A patent/BRPI0813725A2/pt not_active IP Right Cessation
- 2008-06-18 EP EP08761179A patent/EP2170957A1/fr not_active Withdrawn
- 2008-06-18 KR KR1020107001185A patent/KR20100034015A/ko not_active Ceased
- 2008-06-19 TW TW097122910A patent/TW200918557A/zh unknown
- 2008-06-19 CL CL2008001826A patent/CL2008001826A1/es unknown
-
2009
- 2009-12-07 IL IL202573A patent/IL202573A0/en unknown
- 2009-12-08 ZA ZA200908711A patent/ZA200908711B/xx unknown
- 2009-12-09 CR CR11152A patent/CR11152A/es not_active Application Discontinuation
- 2009-12-17 TN TNP2009000529A patent/TN2009000529A1/fr unknown
- 2009-12-17 CO CO09144825A patent/CO6251325A2/es not_active Application Discontinuation
- 2009-12-18 EC EC2009009812A patent/ECSP099812A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL202573A0 (en) | 2011-08-01 |
| US20090074747A1 (en) | 2009-03-19 |
| ECSP099812A (es) | 2010-01-29 |
| CO6251325A2 (es) | 2011-02-21 |
| US8101182B2 (en) | 2012-01-24 |
| ZA200908711B (en) | 2010-08-25 |
| PE20090768A1 (es) | 2009-07-09 |
| TW200918557A (en) | 2009-05-01 |
| BRPI0813725A2 (pt) | 2014-12-30 |
| KR20100034015A (ko) | 2010-03-31 |
| CR11152A (es) | 2010-01-20 |
| CL2008001826A1 (es) | 2009-02-20 |
| WO2008155365A1 (fr) | 2008-12-24 |
| JP2010530233A (ja) | 2010-09-09 |
| AU2008265128A1 (en) | 2008-12-24 |
| EA201000006A1 (ru) | 2010-10-29 |
| CA2691157A1 (fr) | 2008-12-24 |
| CN102027012A (zh) | 2011-04-20 |
| EP2170957A1 (fr) | 2010-04-07 |
| AR067045A1 (es) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000529A1 (en) | Methods and compositions for treating allergic diseases | |
| TW200736275A (en) | Methods and compositions for treating allergic diseases | |
| MY165273A (en) | Anti-cd48 antibodies and uses thereof | |
| PH12012500843A1 (en) | Engineered anti-tslp antibody | |
| MX2010004327A (es) | Anticuerpos anti-vegf completamente humanos y metodos de uso. | |
| PH12015501806A1 (en) | Novel benzopyran kinase modulators | |
| PH12013500355A1 (en) | Engineered anti-tslp antibody | |
| PH12017500864A1 (en) | Anti-notch1 antibodies | |
| MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
| SG178602A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| PH12012500774A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| PH12012500815A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| MX2012004415A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| MX2012001262A (es) | Inmunoglobulinas de dominio variable doble y usos de las misma. | |
| MX2011011669A (es) | Inmunoglobulinas de dominio variable dual y usos de las misma. | |
| MX2010008688A (es) | Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. | |
| MX346172B (es) | Anticuerpos anti - cxcr5 humanizados, derivados de los mismos y su uso. | |
| MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| MX2013001267A (es) | ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD. | |
| MX2014001766A (es) | Anticuerpos de neuregulina y sus usos. | |
| PH12015501360A1 (en) | Bmp-6 antibodies | |
| MX357166B (es) | Anticuerpos que se unen a notum pectinacetilesterasa. | |
| AU2014256372B2 (en) | New compositions for treating CMT and related disorders | |
| MX2010003373A (es) | Moduladores de receptores muscarinicos. | |
| TN2010000463A1 (en) | Compositions and methods for preparing and using same |